VisiCELL Medical

VisiCELL Medical

Private
San Diego, CaliforniaHealthcare & Life Scienceshttp://www.visicellmedical.com

Last Round

Accelerator

Jun 10, 2025

Total Funding Raised

$1.28M

Company Overview

VisiCELL Medical is a biotechnology company that develops non-invasive, imaging-based solutions for the cell therapy industry. The company's core technology, described as a "GPS for cell therapy," allows for the real-time tracking of therapeutic cells, such as CAR-T and stem cells, after they are administered to a subject. This is intended to help researchers and clinicians assess treatment safety and effectiveness, accelerating the development and time-to-market for new cell-based therapies for diseases like cancer, Parkinson's, and Alzheimer's. Their technology is based on a clinically applicable imaging tool using proprietary, biodegradable nanoparticles to label cells for tracking. The company was founded in 2012 by Amilcare Gentili and Mya S Thu and is based in San Diego, California.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Imaging, Biotech Equipment, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

cell labelingin vivo cell trackingtheranostic nanomaterialscell therapyCAR-T cell trackingstem cell trackingGPS for cell therapyMRI cell trackingliving drugscell biodistributioncell labeling kitoptical imagingclinical trial toolspre-clinical researchbiodegradable nanoparticles

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VisiCELL Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VisiCELL Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 10, 2025
GrantMar 1, 2022
Convertible DebtMar 10, 2021

Key People

Founding team and executive leadership

Mya S. Thu

Co-Founder And CEO

Founding Team

Johnny Akers

Chief Operating Officer

Executive Team

VisiCELL Medical Investors

Notable investors and investment history

VisiCELL Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VisiCELL Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VisiCELL Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Diego, California
Employee Range11
Year Founded2012
Last FundingJun 10, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.